In mouse models of SLE, BTKi was successful, but as BDCA‐2 is exclusively found in humans, the enhancement of IFN‐α production by blocking the BDCA‐2 pathway with BTKi could not be mirrored in those models. Here, IBTK is linked to systemic lupus erythematosus.